Brind.

Ideaya Biosciences presented data on its drug darovasertib for melanoma at the ESMO meeting in Berlin.

1 report, 1 independent Updated Jul 24
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Some supportReported by 1 outlet

Ideaya Biosciences presented data on its drug darovasertib for melanoma at the ESMO meeting in Berlin.

Who's involved

What this event is mainly about
Ideaya Biosciences (United States)

Keep exploring

The entities involved

Coverage

Newest first; wire copies grouped
  • PR NewswireIDEAYA Biosciences Announces Proffered Paper Oral Presentation at ESMO 2025 for Phase 2 Clinical Trial of Neoadjuvant Darovasertib in Primary Uveal Melanoma The presentation will include data from ov